Skip to main content
Top
Published in: Indian Journal of Thoracic and Cardiovascular Surgery 3/2019

Open Access 01-07-2019 | Review Article

TAVI—thick on technology but thin on evidence

Author: Kunal Sarkar

Published in: Indian Journal of Thoracic and Cardiovascular Surgery | Issue 3/2019

Login to get access

Abstract

Transcatheter aortic valve implantation (TAVI) has emerged as one of the most popularly deployed interventional innovations of recent times. After addressing the inoperable and high-risk patients, it is application is being extended to intermediate and low-risk category. There is some disquiet about the strength of evidence on which the clinical application is based. Durability and pacemaker requirement are also areas of concern. This review highlights the areas of concern on these aspects. There is also a need to address these deficiencies in future trials and also bring updated database reports in the public domain.
Literature
1.
go back to reference Van Brabandt H, Neyt M, Hulstaert F. Transcatheter Aortic valve implantation (TAVI): risky and costly. BMJ. 2012;345:e4710.CrossRefPubMed Van Brabandt H, Neyt M, Hulstaert F. Transcatheter Aortic valve implantation (TAVI): risky and costly. BMJ. 2012;345:e4710.CrossRefPubMed
2.
go back to reference Kappetein AP, Head SJ, Genereux P, et al. Updates standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium -2 consensus document. Eur Heart J. 2012;33:2403–18.CrossRefPubMed Kappetein AP, Head SJ, Genereux P, et al. Updates standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium -2 consensus document. Eur Heart J. 2012;33:2403–18.CrossRefPubMed
3.
go back to reference Mylotte D, Osnabrugge RLJ, Windecker S, et al. Transcatheter aortic valve replacement in Europe adoption trends and factors influencing device utilization. J Am Coll Cardiol. 2013;62:210–9.CrossRefPubMed Mylotte D, Osnabrugge RLJ, Windecker S, et al. Transcatheter aortic valve replacement in Europe adoption trends and factors influencing device utilization. J Am Coll Cardiol. 2013;62:210–9.CrossRefPubMed
4.
go back to reference Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic- valve replacement in high- risk patients. N Engl J Med. 2011;364:2187–98.CrossRefPubMed Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic- valve replacement in high- risk patients. N Engl J Med. 2011;364:2187–98.CrossRefPubMed
5.
go back to reference Leon MB, Smith CR, Mack MJ, et al. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2016;374:1609–20.CrossRefPubMed Leon MB, Smith CR, Mack MJ, et al. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2016;374:1609–20.CrossRefPubMed
6.
go back to reference Neyt M, Van Brabandt H. TAVI: reveal the truth, the whole truth, and nothing but the truth. J Med Econ. 2013;16:581–5.CrossRefPubMed Neyt M, Van Brabandt H. TAVI: reveal the truth, the whole truth, and nothing but the truth. J Med Econ. 2013;16:581–5.CrossRefPubMed
7.
9.
go back to reference Storteky S, Windecker S, Pilgrim T, et al. Cerebrovascular accidents complicating transcatheter aortic valve implantation: frequency, timing and impact on outcomes. EuroIntervention. 2012;8:62–70.CrossRef Storteky S, Windecker S, Pilgrim T, et al. Cerebrovascular accidents complicating transcatheter aortic valve implantation: frequency, timing and impact on outcomes. EuroIntervention. 2012;8:62–70.CrossRef
11.
go back to reference Nishimura RA, Otto CM, Bonow RO, et al. 2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the management of patients with Valvular Heart Disease: A report of the American College of cardiology/ American Heart Association Task force on Clinical Practice guidelines. Circulation. 2017;135:e1159–95.CrossRefPubMed Nishimura RA, Otto CM, Bonow RO, et al. 2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the management of patients with Valvular Heart Disease: A report of the American College of cardiology/ American Heart Association Task force on Clinical Practice guidelines. Circulation. 2017;135:e1159–95.CrossRefPubMed
13.
go back to reference Chakos A, Wilson-Smith A, Arora S, et al. Long term outcomes of trascatheter aortic valve implantation (TAVI): a systemic review of 5 year survival and beyond. Ann Cardiothorac Surg. 2017:432–43. Chakos A, Wilson-Smith A, Arora S, et al. Long term outcomes of trascatheter aortic valve implantation (TAVI): a systemic review of 5 year survival and beyond. Ann Cardiothorac Surg. 2017:432–43.
15.
go back to reference Möllmann H, Kim WK, Kempfert J, Walther T, Hamm C. Complications of transcatheter aortic valve implantation (TAVI): how to avoid and treat them. Heart. 2015;101:900–8.CrossRefPubMed Möllmann H, Kim WK, Kempfert J, Walther T, Hamm C. Complications of transcatheter aortic valve implantation (TAVI): how to avoid and treat them. Heart. 2015;101:900–8.CrossRefPubMed
16.
go back to reference Hamm CW, Mollmann H, Holzhey D, et al. The German Aortic valve Registry (GARY): in-hospital outcome. Eur Heart J. 2014;35:1588–98.CrossRefPubMed Hamm CW, Mollmann H, Holzhey D, et al. The German Aortic valve Registry (GARY): in-hospital outcome. Eur Heart J. 2014;35:1588–98.CrossRefPubMed
17.
go back to reference Grover FL, Vemulapalli S, Carroll JD, et al. 2016 Annual report of the Society of Thoracic Surgeons/ American College of Cardiology. Transcatheter valve therapy registry. J Am Coll Cardiol. 2017;69:1215–30.CrossRefPubMed Grover FL, Vemulapalli S, Carroll JD, et al. 2016 Annual report of the Society of Thoracic Surgeons/ American College of Cardiology. Transcatheter valve therapy registry. J Am Coll Cardiol. 2017;69:1215–30.CrossRefPubMed
18.
go back to reference Werner N, Zahn R, Backmann A, et al. Patients at intermediate risk undergoing isolated interventional or surgical aortic valve replacement for severe symptomatic aortic valve stenosis. One year results from the German Aortic Valve Registry (GARY). Presented at: American Heart Association Scientific Sessions 2016. New Orleans, LA; 2016 Werner N, Zahn R, Backmann A, et al. Patients at intermediate risk undergoing isolated interventional or surgical aortic valve replacement for severe symptomatic aortic valve stenosis. One year results from the German Aortic Valve Registry (GARY). Presented at: American Heart Association Scientific Sessions 2016. New Orleans, LA; 2016
20.
go back to reference Genreux P, Head SJ, Van Mieghem NM, et al. Clinical Outcomes after transcatheter aortic valve replacement using valve academic research consortium definitions: a weighted meta-analysis of 3519 patients from 16 studies. J Am Coll Cardiol. 2012;59:2317–26.CrossRef Genreux P, Head SJ, Van Mieghem NM, et al. Clinical Outcomes after transcatheter aortic valve replacement using valve academic research consortium definitions: a weighted meta-analysis of 3519 patients from 16 studies. J Am Coll Cardiol. 2012;59:2317–26.CrossRef
21.
go back to reference Houthuizen P, van der Boon RM, Urena M, et al. Occurrence, fate and consequences of ventricular conduction abnormalities after transcatheter aortic valve implantation. EuroIntervention. 2014;9:1142–50.CrossRefPubMed Houthuizen P, van der Boon RM, Urena M, et al. Occurrence, fate and consequences of ventricular conduction abnormalities after transcatheter aortic valve implantation. EuroIntervention. 2014;9:1142–50.CrossRefPubMed
22.
go back to reference Eggebrecht H, Schmermund A, Voigtländer T, Kahlert P, Erbel R, Mehta RH. Risk of stroke after transcatheter valve implantation (TAVI): a meta-analysis of 10,037 published patients. EuroIntervention. 2012;8:129–38.CrossRefPubMed Eggebrecht H, Schmermund A, Voigtländer T, Kahlert P, Erbel R, Mehta RH. Risk of stroke after transcatheter valve implantation (TAVI): a meta-analysis of 10,037 published patients. EuroIntervention. 2012;8:129–38.CrossRefPubMed
23.
go back to reference Arora S, Ramm CJ, Misenheimer JA, Vavalle JP. Early transcatheter valve prosthesis degeneration and future ramification. Cardiovasc Diagn Ther. 2017;7:1–3.CrossRefPubMedPubMedCentral Arora S, Ramm CJ, Misenheimer JA, Vavalle JP. Early transcatheter valve prosthesis degeneration and future ramification. Cardiovasc Diagn Ther. 2017;7:1–3.CrossRefPubMedPubMedCentral
24.
go back to reference Dasi LP, Hatoum H, Kheradvar A, et al. On the mechanics of transcatheter aortic valve replacement. Ann Biomed Eng. 2017;45:310–31.CrossRefPubMed Dasi LP, Hatoum H, Kheradvar A, et al. On the mechanics of transcatheter aortic valve replacement. Ann Biomed Eng. 2017;45:310–31.CrossRefPubMed
25.
go back to reference Goldstone AB, Chiu P, Baiocchi M, et al. Mechanical or Biological Prostheses for Aortic-Valve and Mitral-Valve replacement. N Engl J Med. 2017;377:1847–57.CrossRefPubMed Goldstone AB, Chiu P, Baiocchi M, et al. Mechanical or Biological Prostheses for Aortic-Valve and Mitral-Valve replacement. N Engl J Med. 2017;377:1847–57.CrossRefPubMed
26.
go back to reference Ludman PF, Moat N, de Belder MA, et al. Transcatheter Aortic Valve Implantation in UK: Temporal trends, Predictors of outcome and a 6 year follow up. A report from the UK TAVI Registry 2007-2012. Circulation. 2015;131:1181–90.CrossRefPubMed Ludman PF, Moat N, de Belder MA, et al. Transcatheter Aortic Valve Implantation in UK: Temporal trends, Predictors of outcome and a 6 year follow up. A report from the UK TAVI Registry 2007-2012. Circulation. 2015;131:1181–90.CrossRefPubMed
27.
go back to reference Hulstaert F, Neyt M, Vinck I, et al. Pre-market clinical evaluations of innovative high-risk medical devices in Europe. Int J Technol Assess Health Care. 2012;28:278–84.CrossRefPubMed Hulstaert F, Neyt M, Vinck I, et al. Pre-market clinical evaluations of innovative high-risk medical devices in Europe. Int J Technol Assess Health Care. 2012;28:278–84.CrossRefPubMed
29.
go back to reference Mylotte D, Osnabrugge RL, Martucci G, Lange R, Kappetein AP, Piazza N. Adoption of transcatherter valve implantation in Western Europe. Interv Cardiol. 2014;9:37–40.PubMedPubMedCentral Mylotte D, Osnabrugge RL, Martucci G, Lange R, Kappetein AP, Piazza N. Adoption of transcatherter valve implantation in Western Europe. Interv Cardiol. 2014;9:37–40.PubMedPubMedCentral
30.
go back to reference Liakopoulos OJ. Transprosthetic leak after biological aortic valve replacement : There is a whole in the valve! J Thorac Cardiovasc Surg. 2017;154:e37–8.CrossRefPubMed Liakopoulos OJ. Transprosthetic leak after biological aortic valve replacement : There is a whole in the valve! J Thorac Cardiovasc Surg. 2017;154:e37–8.CrossRefPubMed
31.
go back to reference Holmes DR Jr, Brennan JM, Rumsfeld JS, et al. Clinical outcomes at 1 year following Transcatheter aortic valve replacement. JAMA. 2015;313:1019–28.CrossRefPubMed Holmes DR Jr, Brennan JM, Rumsfeld JS, et al. Clinical outcomes at 1 year following Transcatheter aortic valve replacement. JAMA. 2015;313:1019–28.CrossRefPubMed
Metadata
Title
TAVI—thick on technology but thin on evidence
Author
Kunal Sarkar
Publication date
01-07-2019
Publisher
Springer Singapore
Published in
Indian Journal of Thoracic and Cardiovascular Surgery / Issue 3/2019
Print ISSN: 0970-9134
Electronic ISSN: 0973-7723
DOI
https://doi.org/10.1007/s12055-018-0731-2

Other articles of this Issue 3/2019

Indian Journal of Thoracic and Cardiovascular Surgery 3/2019 Go to the issue